Skip to main content
. Author manuscript; available in PMC: 2010 Oct 25.
Published in final edited form as: Gastroenterology. 1987 Oct;93(4):681–686. doi: 10.1016/0016-5085(87)90428-8

Figure 1.

Figure 1

Variation in specific [3H]R1881 in rat liver of male rats treated with spironolactone (SPIRO) or potassium canrenoate (K-CAN). Specific [3H]R1881 binding was quantitated as described in Methods and is expressed as femtomoles per gram liver. Total hepatic receptor content is shown in A, nuclear receptor in B, and cytosolic receptor in C. Serum testosterone levels are shown in D. All groups consisted of at least 5 animals; the values are expressed as mean ± SD. *Different from control, p < 0.05.